[ Back to EurekAlert! ]

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital

Fusion Protein Activates Immune Cells Against Tumors

Caption: The Jantibody fusion protein, combining an antibody fragment targeting an antigen found on tumor cells with an immune-response-inducing protein, MTBhsp70, activates dendritic cells against several tumor antigens and induces a number of T-cell-based immune responses.

Credit: Jianping Yuan, Ph.D., Massachusetts General Hospital Vaccine and Immunotherapy Center

Usage Restrictions: None

Related news release: Novel cancer vaccine holds promise against ovarian cancer, mesothelioma


[ Back to EurekAlert! ]